J Cell Sci 2009,122(Pt 12):2043–2054 PubMedCrossRef 23 Hosotani

J Cell Sci 2009,122(Pt 12):2043–2054.PubMedCrossRef 23. Hosotani R, Kawaguchi M, Masui T, Koshiba T, Ida J, Fujimoto K, Wada M, Doi R, Imamura M: Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis. Pancreas 2002,25(2):e30–35.PubMedCrossRef 24. Mercapide J, Lopez De Cicco R, Castresana JS, Klein-Szanto AJ: Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. Int

J Cancer 2003,106(5):676–682.PubMedCrossRef 25. Korc M: Pathways for aberrant angiogenesis in pancreatic cancer. Mol Cancer 2003, 2:8.PubMedCrossRef 26. Robinson CJ, Stringer SE: The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 2001,114(Pt 5):853–865.PubMed 27. Seo Y, Baba H, Fukuda T, Takashima M, Sugimachi K: High selleckchem expression of vascular DihydrotestosteroneDHT ic50 endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal

pancreatic adenocarcinoma. Cancer 2000,88(10):2239–2245.PubMedCrossRef 28. Luo J, Guo P, Matsuda K, Truong N, Lee A, Chun C, Cheng SY, Korc M: Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo. Int J Cancer 2001,92(3):361–369.PubMedCrossRef 29. Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I, et al.: Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 2004,10(10):3291–3300.PubMedCrossRef 30. Giatromanolaki A, Koukourakis MI, Sivridis E, O’Byrne K, Cox G, Thorpe PE, Gatter KC, Harris AL: Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer https://www.selleckchem.com/products/beta-nicotinamide-mononucleotide.html suggests coactivation of angiogenic and migration pathways. Clin Cancer Res 2000,6(5):1917–1921.PubMed 31. Heo SH, Choi YJ, Ryoo HM, Cho JY: Expression profiling of ETS and MMP factors in VEGF-activated

endothelial cells: Role of MMP-10 in VEGF-induced Smoothened angiogenesis. Journal of cellular physiology 2010, in press. 32. Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, et al.: Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer 2005,104(2):427–438.PubMedCrossRef 33. Itakura J, Ishiwata T, Friess H, Fujii H, Matsumoto Y, Buchler MW, Korc M: Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res 1997,3(8):1309–1316.PubMed 34. Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, et al.: Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 1999,79(9–10):1553–1563.PubMedCrossRef 35.

Comments are closed.